放射毒性治療市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、適應症、放射類型、最終用戶、地區和競爭細分，2020 年至 2030 年

2024 年全球放射毒性治療市場價值為 24.8 億美元，預計在預測期內將穩定成長，到 2030 年的複合年成長率為 5.40%。近年來，全球放射毒性治療市場經歷了顯著的成長和演變，這得益於癌症發病率的上升以及放射療法在癌症治療中的應用範圍的擴大。放射療法雖然是腫瘤學中的重要工具，但會導致放射毒性，這通常需要專門的治療和管理策略。該市場涵蓋了旨在減輕和治療放射療法不良影響的廣泛產品和服務，使其成為現代癌症治療的重要組成部分。

該市場成長的主要驅動力是全球癌症負擔的增加。隨著全球癌症發生率持續上升，接受放射治療的患者數量大幅增加。然而，放射治療並非沒有副作用，包括皮膚反應、胃腸道問題和器官損傷在內的放射毒性是一個常見的問題。這刺激了對輻射毒性治療方案的需求，包括藥品、醫療設備和支持性護理服務。藥品是放射毒性治療市場的一個重要部分，其中的藥物和藥品旨在控制和緩解放射毒性症狀。這些藥物包括抗發炎劑、生長因子和放射防護藥物。此外，標靶治療和免疫調節劑的進步有望提高放射治療的有效性，同時降低相關毒性。

主要市場促進因素

癌症盛行率上升

主要市場挑戰

認知和教育有限

主要市場趨勢

放射防護藥物和支持性治療

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第 4 章：顧客之聲

第5章：放射毒性治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 副產物（集落刺激因子、碘化鉀、普魯士藍二乙烯三胺五乙酸等）
  • 依適應症（急性放射綜合症、慢性放射綜合症）
  • 依輻射類型（電離輻射、非電離輻射）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美放射毒性治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第7章：歐洲放射毒性治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太放射毒性治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲放射毒性治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲放射毒性治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 13 章：全球放射毒性治療市場：SWOT 分析

第 14 章：競爭格局

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Radiation Toxicity Treatment Market was valued at USD 2.48 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.40% through 2030. The Global Radiation Toxicity Treatment Market has witnessed significant growth and evolution in recent years, driven by the increasing incidence of cancer and the expanding use of radiation therapy in cancer treatment. Radiation therapy, while a crucial tool in oncology, can lead to radiation toxicity, which often necessitates specialized treatments and management strategies. This market encompasses a wide range of products and services aimed at mitigating and treating the adverse effects of radiation therapy, making it an essential component of modern cancer care.

The primary drivers of this market's growth is the rising global cancer burden. As cancer incidence continues to rise worldwide, the number of patients undergoing radiation therapy has increased substantially. However, radiation therapy is not without its side effects, and radiation toxicity, including skin reactions, gastrointestinal issues, and organ damage, is a common concern. This has spurred the demand for radiation toxicity treatment options, including pharmaceuticals, medical devices, and supportive care services. Pharmaceuticals form a crucial segment of the radiation toxicity treatment market, with drugs and medications developed to manage and alleviate the symptoms of radiation toxicity. These pharmaceuticals include anti-inflammatory agents, growth factors, and radioprotective drugs. Additionally, advancements in targeted therapies and immunomodulators hold promise for improving the effectiveness of radiation therapy while reducing associated toxicities.

Key Market Drivers

Increasing Cancer Prevalence

The escalating global incidence of cancer significantly propels the growth of the Radiation Toxicity Treatment Market. This surge in cancer cases leads to increased utilization of radiation therapy, consequently amplifying the demand for treatments addressing radiation-induced toxicities. Recent studies indicate a substantial rise in cancer cases worldwide. For instance, projections suggest in 2022, approximately 20 million new cancer cases were reported globally, resulting in nearly 10 million deaths. Demographic projections suggest that the annual incidence of cancer will rise to 35 million by 2050, representing a 77% increase from 2022 figures. This surge is particularly pronounced in low- and middle-income countries, where healthcare infrastructure may struggle to accommodate the growing burden.

Key Market Challenges

Limited Awareness and Education

One of the primary challenges is the lack of awareness among patients undergoing radiation therapy. For many individuals diagnosed with cancer, the focus understandably shifts to the cancer itself and its treatment. Patients may not be fully informed about the potential side effects of radiation therapy, which can include skin irritation, fatigue, gastrointestinal issues, and damage to healthy tissues. Consequently, they may not actively seek information about radiation toxicity treatment options that could mitigate these adverse effects.

This lack of awareness can lead to suboptimal patient experiences, as individuals may not be proactive in discussing radiation toxicity concerns with their healthcare providers. As a result, they may endure unnecessary discomfort and a reduced quality of life during their treatment journey.

Key Market Trends

Radioprotective Agents and Supportive Care

Radioprotective agents and supportive care have emerged as powerful drivers boosting the Global Radiation Toxicity Treatment Market. These components of radiation toxicity management are gaining increasing attention and significance in the field of cancer care.

Radioprotective agents are pharmaceuticals and treatments developed to shield healthy tissues from the damaging effects of radiation therapy while simultaneously enhancing the tumor's sensitivity to radiation. These agents are designed to minimize radiation-induced toxicities, making radiation therapy safer and more tolerable for patients. The development of radioprotective drugs represents a major breakthrough, as it allows oncologists to optimize radiation treatment protocols without compromising their efficacy. As a result, patients can receive higher doses of radiation to target cancer cells more effectively while experiencing fewer side effects, driving the demand for such agents and boosting the radiation toxicity treatment market.

Key Market Players

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc

Report Scope:

In this report, the Global Radiation Toxicity Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiation Toxicity Treatment Market, By Product:

• Colony Stimulating Factors
• Potassium Iodide
• Prussian Blue Diethylenetriamine Pentaacetic Acid
• Others

Radiation Toxicity Treatment Market, By Indication:

• Acute Radiation Syndrome
• Chronic Radiation Syndrome

Radiation Toxicity Treatment Market, By End-user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Radiation Toxicity Treatment Market, By Radiation Type:

• Ionizing Radiation
• Non-ionizing Radiation

Radiation Toxicity Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiation Toxicity Treatment Market.

Available Customizations:

Global Radiation Toxicity Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Radiation Toxicity Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue Diethylenetriamine Pentaacetic Acid, Others)
  • 5.2.2. By Indication (Acute Radiation Syndrome, Chronic Radiation Syndrome)
  • 5.2.3. By Radiation Type (Ionizing Radiation, Non-ionizing Radiation)
  • 5.2.4. By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Radiation Toxicity Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Radiation Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Radiation Toxicity Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Radiation Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Radiation Toxicity Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Radiation Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Radiation Toxicity Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Radiation Type
      • 6.3.3.2.4. By End User

7. Europe Radiation Toxicity Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Radiation Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Radiation Toxicity Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Radiation Type
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Radiation Toxicity Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Radiation Type
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Radiation Toxicity Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Radiation Type
      • 7.3.3.2.4. By End User
  • 7.3.4. France Radiation Toxicity Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Radiation Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Radiation Toxicity Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Radiation Type
      • 7.3.5.2.4. By End User

8. Asia-Pacific Radiation Toxicity Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Radiation Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Radiation Toxicity Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Radiation Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Radiation Toxicity Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Radiation Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Radiation Toxicity Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Radiation Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Radiation Toxicity Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Radiation Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Radiation Toxicity Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Radiation Type
      • 8.3.5.2.4. By End User

9. South America Radiation Toxicity Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Radiation Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Radiation Toxicity Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Radiation Type
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Radiation Toxicity Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Radiation Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Radiation Toxicity Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Radiation Type
      • 9.3.3.2.4. By End User

10. Middle East and Africa Radiation Toxicity Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Radiation Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Radiation Toxicity Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Radiation Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Radiation Toxicity Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Radiation Type
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Radiation Toxicity Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Radiation Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Radiation Toxicity Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Amgen Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Jubilant Pharma Limited
• 14.3. Tanner Pharma Group
• 14.4. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• 14.5. Recipharm AB
• 14.6. Mission Pharmacal Company
• 14.7. Partner Therapeutics, Inc.
• 14.8. Novartis AG
• 14.9. Viatris Inc.
• 14.10.Coherus Biosciences Inc.

15. Strategic Recommendations

16. About Us & Disclaimer